Halozyme to Report First Quarter 2024 Financial and Operating Results
Go back to Halozyme to Report First Quarter 2024 Financial and Operating Results| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 76.11 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $76.11 | 52 Week High | $18.39 | |||
| Open | $76.11 | 52 Week Low | $6.96 | |||
| Day High | $76.11 | P/E | N/A | |||
| Day Low | $76.11 | EPS | $-0.58 | |||
| Volume | 977 | |||||
